17.19

2.62% -0.58

Novocure Ltd (NVCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NVCR Giù? Forum Previsione

Precedente Chiudi:

$17.77

Aprire:

$17.75

Volume 24 ore:

334.64K

Relative Volume:

0.21

Capitalizzazione di mercato:

$2.00B

Reddito:

$674.41M

Utile/perdita netta:

$-173.05M

Rapporto P/E:

-11.20

EPS:

-1.5343

Flusso di cassa netto:

$-48.07M

1 W Prestazione:

+2.09%

1M Prestazione:

+8.16%

6M Prestazione:

+52.33%

1 anno Prestazione:

+45.30%

Intervallo 1D:

$17.18

$17.82

Intervallo di 1 settimana:

$16.78

$18.61

Portata 52W:

$9.82

$21.45

Novocure Ltd Stock (NVCR) Company Profile

Nome

Novocure Ltd

Settore

Healthcare (1087)

Industria

Medical Devices (140)

Telefono

44 (0)15 3475 6700

Indirizzo

NO. 4 THE FORUM, ST. HELIER

Dipendente

1,605

Cinguettio

@novocure

Prossima data di guadagno

2026-07-23

Ultimi documenti SEC

NVCR's Discussions on Twitter

Compare NVCR vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NVCR Novocure Ltd	17.18	2.12B	674.41M	-173.05M	-48.07M	-1.5343
ABT Abbott Laboratories	116.42	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	331.36	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	93.15	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	50.73	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.90	53.19B	6.30B	1.07B	1.09B	1.8406

Novocure Ltd Stock (NVCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-07-08	Iniziato	Ladenburg Thalmann	Buy
2024-12-02	Aggiornamento	Evercore ISI	In-line → Outperform
2024-10-16	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-11-20	Ripresa	JP Morgan	Neutral
2023-08-28	Downgrade	H.C. Wainwright	Buy → Neutral
2023-08-08	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-08-04	Iniziato	SVB Securities	Outperform
2023-07-31	Aggiornamento	Evercore ISI	Underperform → In-line
2023-06-07	Aggiornamento	Wedbush	Underperform → Neutral
2023-05-16	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-17	Downgrade	JP Morgan	Neutral → Underweight
2023-01-06	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-01-05	Reiterato	H.C. Wainwright	Buy
2022-11-29	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-10-24	Downgrade	Piper Sandler	Overweight → Neutral
2022-07-05	Downgrade	Evercore ISI	In-line → Underperform
2022-05-16	Iniziato	H.C. Wainwright	Buy
2022-02-08	Iniziato	Loop Capital	Buy
2022-02-02	Aggiornamento	Oppenheimer	Perform → Outperform
2022-01-20	Aggiornamento	Truist	Hold → Buy
2022-01-03	Aggiornamento	Evercore ISI	Underperform → In-line
2021-07-01	Downgrade	Mizuho	Buy → Neutral
2021-04-14	Downgrade	Wedbush	Neutral → Underperform
2021-01-25	Reiterato	Piper Sandler	Overweight
2020-09-23	Iniziato	Northland Capital	Outperform
2020-09-18	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-09-17	Downgrade	Truist	Buy → Hold
2020-06-01	Ripresa	Oppenheimer	Perform
2020-05-01	Downgrade	Oppenheimer	Outperform → Perform
2020-04-09	Downgrade	Evercore ISI	In-line → Underperform
2020-03-05	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-07-29	Aggiornamento	SunTrust	Hold → Buy
2019-07-26	Downgrade	JP Morgan	Overweight → Neutral
2019-07-26	Downgrade	Wedbush	Outperform → Neutral
2019-03-20	Iniziato	SunTrust	Hold
2018-11-02	Downgrade	Wells Fargo	Outperform → Market Perform
2018-07-16	Iniziato	Evercore ISI	Outperform
2018-04-18	Reiterato	Mizuho	Buy
2018-02-23	Reiterato	Mizuho	Buy
2017-05-24	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-07-29	Reiterato	Wedbush	Outperform
2016-01-19	Iniziato	Barclays	Underweight
2015-12-02	Iniziato	Deutsche Bank	Hold

Mostra tutto

Novocure Ltd Borsa (NVCR) Ultime notizie

Aug 20, 2026

Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice - Yahoo Finance

Aug 20, 2026

NVCR Q2 2026 Earnings: Loss Narrower Than Expected; Shares Slip 0.82Earnings Preview - Vinanet

Aug 13, 2026

Aug 12, 2026

Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet - Yahoo Finance

Aug 12, 2026

NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials ProgressHas The Bull Case Changed? - simplywall.st

Aug 12, 2026

Sei Investments Co. Buys 89,839 Shares of NovoCure Limited $NVCR - MarketBeat

Aug 12, 2026

Aug 11, 2026

First Trust Advisors LP Invests $1.03 Million in NovoCure Limited $NVCR - marketbeat.com

Aug 11, 2026

Aug 10, 2026

NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued - simplywall.st

Aug 10, 2026

Aug 08, 2026

NovoCure (NASDAQ:NVCR) Rating Increased to Buy at Wall Street Zen - MarketBeat

Aug 08, 2026

Aug 07, 2026